Richard, Shambavi
Jagannath, Sundar http://orcid.org/0000-0003-2934-6518
Article History
Accepted: 10 December 2021
First Online: 3 February 2022
Declarations
:
: No external funding was used in the preparation of this manuscript.
: Dr. Richard has served as a consultant for Karyopharm Therapeutics and Bristol-Myers Squibb and has received honoraria from Janssen Pharmaceuticals. Dr. Jagannath is a consultant for Bristol-Myers Squibb, Janssen Pharmaceuticals, Karyopharm Therapeutics, Legend Biotech, Takeda, and Sanofi.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Both authors have contributed equally to the work on the manuscript.